Dickkopf 2 serves as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia targeted by evodiamine

ObjectiveAcute myeloid leukemia (AML) has seen a significant increase in cases recently, often leading to a poor outlook. Dysregulated cell death is a characteristic of AML that aids in both the formation and advancement of the disease. Dickkopf 2 (DKK2) is known to promote tumorigenesis and metasta...

Full description

Bibliographic Details
Published in:Frontiers in Medicine
Main Authors: Rui Li, Weiguang Jiang, Xiaomei Sun, Yan-Hua Su
Format: Article
Language:English
Published: Frontiers Media S.A. 2026-04-01
Subjects:
acute myeloid leukemia
Dickkopf 2
evodiamine
function
molecular docking
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2026.1767391/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2026.1767391/full

Similar Items